VieCure
An artificial intelligence platform and cancer knowledge base that empowers providers to personalize and manage patient care to make seemingly impossible outcomes possible and to make overcoming cancer a reality for patients while optimizing resources to yield better financial results.
A reimagined neural operating system for cancer providers.
Shaping the Future of Cancer Care
Our Mission
To ensure that every cancer patient lives their best life. Our focus is the patient.
We accomplish this by following our 4 values:
Agility; Urgency; Innovation; Impact.
We challenge the status quo and challenge you to ask yourself - are your software tools assisting you in helping cancer patients live their best lives?
Our Philosophy
We believe precision medicine, value based care, and NGS are the future of cancer care.
We don't seek out clients, but rather we're looking for partners who share that belief.
Cancer practices are still using tools built 20 to 30 years ago. Why? Do you believe there is a paradigm shift in Oncology? Do you believe your current tools were built for that shift?
Why Choose Us
100 +
Years of Cancer Leadership Experience
80 +
Cancer Center Locations Contracted
280 +
Contracted Providers in Network
VieCure | Competitors | |
|---|---|---|
Client and platform focus/time to market | Yes | No |
Integrated physician
mobile APP | Yes | No |
Voice automation
| Yes | No |
Prior authorization
interlocks | Yes | No |
Codified clinical
content library | Yes | No |
Integrated tele-oncology | Yes | No |
Integrated precision oncology / NGS functionality | Yes | No |
Integrated remote patient therapy monitoring | Yes | No |
A.I. clinical
inference engine | Yes | No |
Comprehensive software ecosystem | Yes | No |
Our Leadership
Combining excellence in cancer care, software, artificial intelligence, and business.
Gerry Hogue
Chairman, President, and CEO
Founder of OpTx Corp
30+ Yrs. Cancer Leadership
Former SVP Elekta North America
Gerry is the founder of VieCure, and presently serves as its President & CEO. He has spent many years working in the field of enabling technologies for cancer care, and is excited to now be leading the charge in genomics-based, personalized medicine that empowers cancer patients and their families.
Michael G. Power
Chief Business Development Officer
Former EVP Cancer Care Ontario
Former CEO Cancer Research Institute
Former SVP Elekta Global Strategic
Michael is the Chief Business Development Officer. He helped found VieCure and leads the Global Business Development portfolio. Michael has more than twenty-years of executive level experience in cancer medicine and is a NHL draftee of the Edmonton Oilers Hockey Club.
Dr. Fred Ashbury
Chief Scientific Officer
Former CSO with OpTx Corp
30+ Years of Cancer Leadership
Former Senior Executive with Cancer Care Ontario
Fred is a co-founder and Chief Scientific Officer at VieCure. He is responsible for developing and maintaining VieCure’s oncology clinical content, genomic-science knowledge identification and codification, and the design and implementation of the treatment strategy rules that underpin our platform. He was the co-founder for Intelligent Improvement Consultants, a healthcare management consulting firm. He is a former senior executive with the National Cancer Institute of Canada, Cancer Care Ontario, and the Alberta Cancer Board, OpTx Corporation, and BridgeSite Clinical Research.
Tony Romano
Vice President, Order Fulfillment
Former EVP, Global Delivery: Origin Utility, Inc.
Former VP, Product Delivery Operations: Vizient, Inc.
Former VP, Advisory Solutions Operations: MedAssets, Inc
Tony brings 20 years of experience in operations management, enterprise transformation, and process improvement across multiple commercial industries and government organizations to the VieCure team. He is a seasoned leader who specializes in translating strategy into execution by creating highly engaged teams, repeatable processes, and actionable metrics. He thrives in undefined and uncertain environments, commercializing ideas into revenue-producing and cost-saving assets.
